Susquehanna International Group’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.4K | Sell |
39,977
-37,893
| -49% | -$30.7K | ﹤0.01% | 6098 |
|
|
2025
Q1 | $59.8K | Buy |
77,870
+5,071
| +7% | +$3.9K | ﹤0.01% | 5985 |
|
|
2024
Q4 | $92.8K | Buy |
+72,799
| New | +$92.8K | ﹤0.01% | 5714 |
|
|
2023
Q2 | – | Sell |
-129,680
| Closed | -$739K | – | 6292 |
|
|
2023
Q1 | $739K | Buy |
129,680
+36,390
| +39% | +$207K | ﹤0.01% | 3302 |
|
|
2022
Q4 | $563K | Buy |
93,290
+79,699
| +586% | +$481K | ﹤0.01% | 3044 |
|
|
2022
Q3 | $90K | Sell |
13,591
-15,837
| -54% | -$105K | ﹤0.01% | 5317 |
|
|
2022
Q2 | $154K | Buy |
+29,428
| New | +$154K | ﹤0.01% | 4755 |
|
|
2022
Q1 | – | Sell |
-29,275
| Closed | -$364K | – | 6347 |
|
|
2021
Q4 | $364K | Buy |
29,275
+9,645
| +49% | +$120K | ﹤0.01% | 4244 |
|
|
2021
Q3 | $613K | Buy |
19,630
+2,477
| +14% | +$77.4K | ﹤0.01% | 3418 |
|
|
2021
Q2 | $491K | Buy |
+17,153
| New | +$491K | ﹤0.01% | 3917 |
|